Unlimited Submissions for NIH Grants?

The National Institutes of Health is weighing a peer-review system where grant proposals, even ones being resubmitted, would be treated as new.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

WIKIMEDIA, VIA FLICKR: PEN WAGGENERCurrently researchers seeking funding from the National Institutes of Health (NIH) can resubmit their grant proposals only once after they have been rejected. But that may soon change. In December, the advisory council for NIH's Center for Scientific Review (CSR) floated a plan to let investigators resubmit unsuccessful grant proposals as many times as they want, with reviewers considering them anew each time.

“The CSR council suggested a pilot study in which investigators would be allowed an unlimited number of resubmissions but no more than two applications over 12 months,” according to ScienceInsider.

The idea is not a new one. It was originally proposed in 2008, when an internal NIH report suggested ending the system that allowed researchers to resubmit their grant applications just twice after initial rejection. Instead, the NIH reduced the number of permitted resubmissions to one. Now, as the success rate for NIH proposals hangs at a dismal 18 percent, the agency is looking for a way to reinvigorate the peer-review process.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Bob Grant

    From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer.
Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino

Products

Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Inventia Life Science

Inventia Life Science Launches RASTRUM™ Allegro to Revolutionize High-Throughput 3D Cell Culture for Drug Discovery and Disease Research

An illustration of differently shaped viruses.

Detecting Novel Viruses Using a Comprehensive Enrichment Panel

Twist Bio 
Zymo Research

Zymo Research Launches Microbiome Grant to Support Innovation in Microbial Sciences